免疫療法藥物市場規模、佔有率、趨勢、行業分析報告（按類型、應用、給藥途徑、最終用戶和地區）- 市場預測，2025-2034 年

根據Polaris Market Research的最新研究，全球免疫療法市場規模預計到2034年將達到11,520.3億美元。該報告提供了有關當前市場動態的詳細見解，並對未來市場的成長進行了分析。

免疫療法市場涉及開發、生產和銷售利用人體免疫系統透過針對特定細胞或途徑治療疾病（尤其是癌症）的藥物。與傳統治療相比，標靶治療的應用越來越多，這極大地推動了免疫治療藥物市場的成長。標靶療法，例如單株抗體，旨在專門攻擊癌細胞或病原體，最大限度地減少對健康細胞的損害，並避免化療等傳統療法中常見的副作用。向更精準、更有效的治療轉變與個人化醫療日益增長的需求相吻合，個人化醫療的治療是根據遺傳和疾病特徵針對個別患者情況量身定制的。因此，預計預測期內免疫療法藥物市場的需求將擴大。

新免疫療法藥物的批准和不斷擴大的應用正在進一步推動市場成長。例如，2024年4月，阿斯特捷利康和第一三共的Enhertu獲得FDA批准，成為首個針對先前接受過治療的轉移性HER2陽性實體瘤的腫瘤靶向HER2治療藥物，是一種標靶免疫療法，體現了解決方案的趨勢。

這些進步正在改善治療結果並幫助免疫療法被廣泛接受為腫瘤學和其他治療領域的標準治療選擇。各種癌症等慢性病的發生率不斷上升，預計將進一步推動這些創新治療方法的需求，以鞏固免疫療法藥物市場的擴張。

近年來，在醫療機構和倡導團體的支持下，人們對該病的認識不斷提高，並提早發現，透過鼓勵及時治療，大大促進了免疫療法市場的發展。這種積極主動的方法有望改善免疫療法的效果。此外，合作和大量研發投資推動的生物技術進步正在推動免疫療法解決方案的創新。透過擴大治療選擇和改善患者護理，它們正在推動市場成長。

免疫治療藥物市場報告重點

抗體藥物在免疫療法市場佔據主導地位，因為它們透過精準標靶療法在治療癌症和自體免疫疾病方面被證明有效。

腫瘤學佔免疫療法市場的最大佔有率，由於未滿足的醫療需求很高且新療法的療效顯著，因此預計腫瘤學將繼續佔據主導地位。

由於癌症發生率高、醫療保健體系強大、生物技術投資巨大以及新療法迅速採用，預計北美將在 2024 年佔據市場最大收入佔有率。

由於醫療保健基礎設施的進步、高疾病盛行率以及強大的臨床試驗和研究管道，亞太地區的免疫療法藥物市場預計將以最快的速度成長。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章 研究方法

第 4 章：全球免疫療法藥物市場洞察

• 市場概況
• 免疫治療市場動態
  • 推動因素和機遇
    • 免疫療法研發活動的進展
    • 免疫療法聯合療法將推動市場成長
  • 阻礙因素和課題
    • 監理障礙與核准延遲
• PESTEL 分析
• 免疫治療藥物市場的應用趨勢
• 價值鏈分析
• COVID-19 影響分析

第 5 章全球免疫療法藥物市場類型

• 主要發現
• 簡介
• 抗體藥物
• 抑制劑
• 幹擾素和白血球介素
• 疫苗
• 其他

第 6 章全球免疫療法藥物市場（按應用）

• 主要發現
• 簡介
• 癌症
• 自體免疫疾病與發炎性疾病
• 血液學
• 骨科
• 神經病學
• 其他

第 7 章依給藥途徑劃分的全球免疫療法市場

• 主要發現
• 簡介
• 靜脈注射
• 皮下
• 口服
• 其他

第 8 章 全球免疫療法藥物市場（依最終用戶劃分）

• 主要發現
• 簡介
• 醫院
• 長期照護機構
• 其他

第 9 章全球免疫治療藥物市場（按地區）

• 主要發現
• 簡介
  • 2020 年至 2034 年各地區免疫療法市場評估
• 北美洲
  2020 年至 2034 年北美各類型 2020 年至 2034 年北美各行政路線
  • 2020 年至 2034 年北美各應用領域
  • 2020 年至 2034 年，北美地區終端用戶分佈
  • 美國
  • 加拿大
• 歐洲
  2020 年至 2034 年歐洲各類型 歐洲，依給藥途徑，2020 年至 2034 年 2020 年至 2034 年歐洲應用狀況 2020 年至 2034 年歐洲終端用戶狀況
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 荷蘭
  • 俄羅斯
  • 其他歐洲國家
  亞太地區
  2020 年至 2034 年亞太地區各類產品 2020 年至 2034 年亞太地區行政路線分佈 2020 年至 2034 年亞太地區應用狀況 2020 年至 2034 年亞太地區最終用戶狀況
  • 中國
  • 印度
  • 馬來西亞
  • 日本
  • 印尼
  • 韓國
  • 澳大利亞
  • 其他亞太地區
• 中東和非洲
  2020 年至 2034 年中東和非洲各類型 2020 年至 2034 年按行政路線劃分的中東和非洲 2020 年至 2034 年中東和非洲的應用狀況 2020 年至 2034 年中東和非洲最終用戶狀況
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲地區
• 拉丁美洲
  2020 年至 2034 年拉丁美洲各類型
  • 2020 年至 2034 年拉丁美洲各行政路線狀況
  • 2020 年至 2034 年拉丁美洲各應用領域狀況 2020 年至 2034 年拉丁美洲最終用戶狀況
  • 墨西哥
  • 巴西
  • 阿根廷
  • 其他拉丁美洲國家

第 10 章 競爭格局

• 擴張與收購分析
  • 放大
  • 收購
• 夥伴關係/協作/協定/揭露

第 11 章 公司簡介

• Abbvie Inc.
• Amgen Inc.
• AstraZeneca
• Bristol-Myers Squibb Company
• F. Hoffman-La Roche Ltd.
• Gilead Sciences, Inc.
• GSK PLC
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceutical Industries Ltd.

The global immunotherapy drugs market size is expected to reach USD 1,152.03 billion by 2034, according to a new study by Polaris Market Research. The report "Immunotherapy Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Antibody Drugs, Inhibitor Drugs, Interferons and Interleukins, Vaccines, and Others), Application, Route of Administration, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The immunotherapy drugs market involves the development, production, and sale of medications that use the body's immune system to treat diseases, particularly cancer, by targeting specific cells or pathways. The rising adoption of targeted therapy over traditional treatment methods is significantly driving the immunotherapy drugs market growth. Targeted therapies, such as monoclonal antibodies, are designed to specifically attack cancer cells or pathogens, which minimizes damage to healthy cells and reduces side effects commonly associated with conventional treatments such as chemotherapy. This shift towards more precise and effective treatments aligns with the increasing demand for personalized medicine, which tailors therapies to individual patient profiles based on genetic and disease characteristics. As a result, the immunotherapy drugs market demand is projected to grow over the forecast period.

The approval of new immunotherapy drugs and the expansion of their applications are further propelling market growth. For instance, in April 2024, AstraZeneca and Daiichi Sankyo's Enhertu were approved by the FDA as the first tumor-agnostic HER2-directed therapy for previously treated metastatic HER2-positive solid tumors, exemplifying the trend toward targeted immunotherapy solutions.

These advancements enhance treatment efficacy and also contribute to a broader acceptance of immunotherapy as a standard care option in oncology and other therapeutic areas. The growing prevalence of chronic diseases, including various cancers, is expected to increase the demand for these innovative therapies further, solidifying the immunotherapy drugs market expansion.

In recent years, increasing awareness and earlier detection of diseases, supported by healthcare organizations and advocacy groups, have significantly enhanced the immunotherapy drugs market by encouraging timely treatment. This proactive approach allows for better outcomes with immunotherapies. Further, advancements in biotechnology driven by research collaborations and substantial investments in R&D are fostering innovation in immunotherapy solutions. Together, these are expanding treatment options and improving patient care, thereby propelling market growth.

Immunotherapy Drugs Market Report Highlights

The antibody drugs segment dominated the immunotherapy drugs market due to their proven efficacy in treating cancers and autoimmune diseases with targeted precision.

The cancer segment held the largest immunotherapy drugs market share and is expected to remain dominant due to high unmet medical needs and the promising results of new therapies.

North America region held the largest revenue share of the market in 2024 due to high cancer prevalence, a robust healthcare system, significant investments in biotechnology, and rapid adoption of new therapies.

The immunotherapy drugs market in Asia Pacific is expected to grow fastest due to advancements in healthcare infrastructure, high disease incidence, and a strong pipeline of clinical trials and research.

The global key market players include Abbvie Inc.; Amgen Inc.; AstraZeneca; Bristol-Myers Squibb Company; F. Hoffman-La Roche Ltd.; Gilead Sciences, Inc.; GSK PLC; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and others.

Polaris Market Research has segmented the immunotherapy drugs market report based on type, application, route of administration, end user, and region:

By Type Outlook

§ Antibody Drugs

§ Inhibitor Drugs

§ Interferons and Interleukins

§ Vaccines

§ Others

By Application Outlook

§ Cancer

§ Autoimmune and Inflammatory Diseases

§ Hematology

§ Osteology

§ Neurology

§ Others

By Route of Administration Outlook

§ Intravenous

§ Subcutaneous

§ Oral

§ Others

By End User Outlook

§ Hospitals

§ Long-Term Care Facilities

§ Others

By Regional Outlook

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Immunotherapy Drugs Market Insights

• 4.1. Immunotherapy Drugs Market - Market Snapshot
• 4.2. Immunotherapy Drugs Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Advancements in Immunotherapy Research & Development Activities
    • 4.2.1.2. Combination Therapies in Immunotherapy Drives Market Growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Regulatory Hurdles and Approval Delays
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Immunotherapy Drugs Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Immunotherapy Drugs Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
• 5.3. Antibody Drugs
  • 5.3.1. Global Immunotherapy Drugs Market, by Antibody Drugs, by Region, 2020-2034 (USD Billion)
• 5.4. Inhibitor Drugs
  • 5.4.1. Global Immunotherapy Drugs Market, by Inhibitor Drugs, by Region, 2020-2034 (USD Billion)
• 5.5. Interferons and Interleukins
  • 5.5.1. Global Immunotherapy Drugs Market, by Interferons and Interleukins, by Region, 2020-2034 (USD Billion)
• 5.6. Vaccines
  • 5.6.1. Global Immunotherapy Drugs Market, by Vaccines, by Region, 2020-2034 (USD Billion)
• 5.7. Other
  • 5.7.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Immunotherapy Drugs Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
• 6.3. Cancer
  • 6.3.1. Global Immunotherapy Drugs Market, by Cancer, by Region, 2020-2034 (USD Billion)
• 6.4. Autoimmune and Inflammatory Diseases
  • 6.4.1. Global Immunotherapy Drugs Market, by Autoimmune and Inflammatory Diseases, by Region, 2020-2034 (USD Billion)
• 6.5. Hematology
  • 6.5.1. Global Immunotherapy Drugs Market, by Hematology, by Region, 2020-2034 (USD Billion)
• 6.6. Osteology
  • 6.6.1. Global Immunotherapy Drugs Market, by Osteology, by Region, 2020-2034 (USD Billion)
• 6.7. Neurology
  • 6.7.1. Global Immunotherapy Drugs Market, by Neurology, by Region, 2020-2034 (USD Billion)
• 6.8. Other
  • 6.8.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Immunotherapy Drugs Market, by Route of Administration

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
• 7.3. Intravenous
  • 7.3.1. Global Immunotherapy Drugs Market, by Intravenous, by Region, 2020-2034 (USD Billion)
• 7.4. Subcutaneous
  • 7.4.1. Global Immunotherapy Drugs Market, by Subcutaneous, by Region, 2020-2034 (USD Billion)
• 7.5. Oral
  • 7.5.1. Global Immunotherapy Drugs Market, by Oral, by Region, 2020-2034 (USD Billion)
• 7.6. Other
  • 7.6.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

8. Global Immunotherapy Drugs Market, by End-User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 8.3. Hospitals
  • 8.3.1. Global Immunotherapy Drugs Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 8.4. Long-Term Care Facilities
  • 8.4.1. Global Immunotherapy Drugs Market, by Long-Term Care Facilities, by Region, 2020-2034 (USD Billion)
• 8.5. Other
  • 8.5.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Immunotherapy Drugs Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Immunotherapy Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Immunotherapy Drugs Market - North America
  • 9.3.1. North America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.3.3. North America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.3.4. North America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.3.5. Immunotherapy Drugs Market - U.S.
    • 9.3.5.1. U.S.: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.3.5.2. U.S.: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.5.3. U.S.: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.4. U.S.: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.3.6. Immunotherapy Drugs Market - Canada
    • 9.3.6.1. Canada: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.4. Immunotherapy Drugs Market - Europe
  • 9.4.1. Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.5. Immunotherapy Drugs Market - UK
    • 9.4.5.1. UK: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.6. Immunotherapy Drugs Market - France
    • 9.4.6.1. France: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.7. Immunotherapy Drugs Market - Germany
    • 9.4.7.1. Germany: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.8. Immunotherapy Drugs Market - Italy
    • 9.4.8.1. Italy: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.9. Immunotherapy Drugs Market - Spain
    • 9.4.9.1. Spain: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.10. Immunotherapy Drugs Market - Netherlands
    • 9.4.10.1. Netherlands: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.11. Immunotherapy Drugs Market - Russia
    • 9.4.11.1. Russia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.12. Immunotherapy Drugs Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.5. Immunotherapy Drugs Market - Asia Pacific
  • 9.5.1. Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.5. Immunotherapy Drugs Market - China
    • 9.5.5.1. China: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.6. Immunotherapy Drugs Market - India
    • 9.5.6.1. India: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.7. Immunotherapy Drugs Market - Malaysia
    • 9.5.7.1. Malaysia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.8. Immunotherapy Drugs Market - Japan
    • 9.5.8.1. Japan: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.9. Immunotherapy Drugs Market - Indonesia
    • 9.5.9.1. Indonesia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.10. Immunotherapy Drugs Market - South Korea
    • 9.5.10.1. South Korea: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.11. Immunotherapy Drugs Market - Australia
    • 9.5.11.1. Australia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.12. Immunotherapy Drugs Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.6. Immunotherapy Drugs Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.5. Immunotherapy Drugs Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.6. Immunotherapy Drugs Market - UAE
    • 9.6.6.1. UAE: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.7. Immunotherapy Drugs Market - Israel
    • 9.6.7.1. Israel: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.8. Immunotherapy Drugs Market - South Africa
    • 9.6.8.1. South Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.9. Immunotherapy Drugs Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.7. Immunotherapy Drugs Market - Latin America
  • 9.7.1. Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.5. Immunotherapy Drugs Market - Mexico
    • 9.7.5.1. Mexico: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.6. Immunotherapy Drugs Market - Brazil
    • 9.7.6.1. Brazil: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.7. Immunotherapy Drugs Market - Argentina
    • 9.7.7.1. Argentina: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.8. Immunotherapy Drugs Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbvie Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Amgen Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. AstraZeneca
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Bristol-Myers Squibb Company
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. F. Hoffman-La Roche Ltd.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Gilead Sciences, Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. GSK PLC
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Johnson & Johnson Services, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Merck & Co., Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Novartis AG
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Pfizer Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Sanofi
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Takeda Pharmaceutical Company Limited.
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Teva Pharmaceutical Industries Ltd.
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development

List of Tables:

Table 1 Global Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 2 Global Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 3 Global Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 4 Global Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 5 North America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 6 North America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 7 North America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 8 North America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 9 U.S.: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 10 U.S.: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 11 U.S.: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 12 U.S.: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 13 Canada: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 14 Canada: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 15 Canada: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 16 Canada: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 17 Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 18 Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 19 Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 20 Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 21 UK: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 22 UK: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 23 UK: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 24 UK: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 25 France: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 26 France: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 27 France: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 28 France: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 29 Germany: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 30 Germany: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 31 Germany: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 32 Germany: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 33 Italy: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 34 Italy: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 35 Italy: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 36 Italy: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 37 Spain: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 38 Spain: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 39 Spain: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 40 Spain: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 41 Netherlands: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 42 Netherlands: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 43 Netherlands: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 44 Netherlands: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 45 Russia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 46 Russia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 47 Russia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 48 Russia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 49 Rest of Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 50 Rest of Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 51 Rest of Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 52 Rest of Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 53 Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 54 Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 55 Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 56 Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 57 China: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 58 China: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 59 China: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 60 China: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 61 India: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 62 India: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 63 India: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 64 India: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 65 Malaysia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 66 Malaysia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 67 Malaysia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 68 Malaysia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 69 Japan: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 70 Japan: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 71 Japan: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 72 Japan: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 73 Indonesia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 74 Indonesia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 75 Indonesia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 76 Indonesia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 77 South Korea: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 78 South Korea: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 79 South Korea: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 80 South Korea: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 81 Australia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 82 Australia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 83 Australia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 84 Australia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 85 Rest of Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 86 Rest of Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 87 Rest of Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 88 Rest of Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 89 Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 90 Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 91 Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 92 Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 93 Saudi Arabia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 94 Saudi Arabia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 95 Saudi Arabia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 96 Saudi Arabia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 97 UAE: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 98 UAE: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 99 UAE: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 100 UAE: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 101 Israel: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 102 Israel: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 103 Israel: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 104 Israel: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 105 South Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 106 South Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 107 South Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 108 South Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 109 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 110 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 111 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 112 Rest of Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 113 Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 114 Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 115 Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 116 Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 117 Mexico: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 118 Mexico: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 119 Mexico: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 120 Mexico: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 121 Brazil: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 122 Brazil: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 123 Brazil: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 124 Brazil: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 125 Argentina: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 126 Argentina: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 127 Argentina: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 128 Argentina: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 129 Rest of Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 130 Rest of Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 131 Rest of Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 132 Rest of Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Immunotherapy Drugs Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global Immunotherapy Drugs Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Route of Administration

Figure 9. Global Immunotherapy Drugs Market, by Route of Administration, 2024 & 2034 (USD Billion)

Figure 10. Market by Application

Figure 11. Global Immunotherapy Drugs Market, by Application, 2024 & 2034 (USD Billion)

Figure 12. Market by End-User

Figure 13. Global Immunotherapy Drugs Market, by End-User, 2024 & 2034 (USD Billion)